These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 17052496)
21. Mercury, hydroquinone and clobetasol propionate in skin lightening products in West Africa and Canada. Gbetoh MH; Amyot M Environ Res; 2016 Oct; 150():403-410. PubMed ID: 27372064 [TBL] [Abstract][Full Text] [Related]
23. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Mahé A; Ly F; Aymard G; Dangou JM Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741 [TBL] [Abstract][Full Text] [Related]
24. Characterization of suspected illegal skin whitening cosmetics. Desmedt B; Van Hoeck E; Rogiers V; Courselle P; De Beer JO; De Paepe K; Deconinck E J Pharm Biomed Anal; 2014 Mar; 90():85-91. PubMed ID: 24334193 [TBL] [Abstract][Full Text] [Related]
25. Survey on skin-lightening practices and cosmetics in Kigali, Rwanda. Kamagaju L; Morandini R; Gahongayire F; Stévigny C; Ghanem G; Pirotte G; Duez P Int J Dermatol; 2016 Jan; 55(1):45-51. PubMed ID: 25773999 [TBL] [Abstract][Full Text] [Related]
26. [Depigmentation for cosmetic purposes: prevalence and side-effects in a female population in Senegal]. Raynaud E; Cellier C; Perret JL Ann Dermatol Venereol; 2001; 128(6-7):720-4. PubMed ID: 11460033 [TBL] [Abstract][Full Text] [Related]
27. Use of skin lightening creams. Survey in a UK general practice. Sidhu SK; Pau N; Sidhu JS; Oakeshott P BMJ; 2011 Mar; 342():d1326. PubMed ID: 21363856 [No Abstract] [Full Text] [Related]
28. [Prevalence of skin disorders associated with the use of bleaching cosmetics by Lome women]. Pitche P; Afanou A; Amanga Y; Tchangaï-Walla K Sante; 1997; 7(3):161-4. PubMed ID: 9296805 [TBL] [Abstract][Full Text] [Related]
30. [Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching]. Sène D; Huong-Boutin DL; Thiollet M; Barete S; Cacoub P; Piette JC Rev Med Interne; 2008 Dec; 29(12):1030-3. PubMed ID: 18586357 [TBL] [Abstract][Full Text] [Related]
31. Exogenous ochronosis: an epidemiological study. Hardwick N; Van Gelder LW; Van der Merwe CA; Van der Merwe MP Br J Dermatol; 1989 Feb; 120(2):229-38. PubMed ID: 2923796 [TBL] [Abstract][Full Text] [Related]
32. [Skin lightening products are a part of everyday life in many parts of the world. Corticosteroids, hydroquinone and mercury are common ingredients]. Wallander M; Löfgren P; Rydén M Lakartidningen; 2015 Jun; 112():. PubMed ID: 26126005 [TBL] [Abstract][Full Text] [Related]
33. Depigmenting procedures and drugs employed by melanoderm populations. Scarpa A; Guerci A J Ethnopharmacol; 1987; 19(1):17-66. PubMed ID: 2438516 [TBL] [Abstract][Full Text] [Related]
34. Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation. Bentley-Phillips B; Bayles MA S Afr Med J; 1975 Aug; 49(34):1391-5. PubMed ID: 1162515 [TBL] [Abstract][Full Text] [Related]
35. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone. Draelos ZD J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437 [TBL] [Abstract][Full Text] [Related]
36. The pursuit of beauty. Druce M; Goldstone AP; Tan TM; Meeran K Lancet; 2008 Feb; 371(9612):596. PubMed ID: 18280330 [No Abstract] [Full Text] [Related]
37. Skin lightening cream induced dermatitis and atrophy. Bremmer M; Gardner J; Driscoll M Dermatol Online J; 2011 Mar; 17(3):13. PubMed ID: 21426879 [TBL] [Abstract][Full Text] [Related]
38. Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks. Hoshaw RA; Zimmerman KG; Menter A Arch Dermatol; 1985 Jan; 121(1):105-8. PubMed ID: 3966811 [TBL] [Abstract][Full Text] [Related]
39. Use of skin lightening creams. Some clinical pointers to use. Adebayo F BMJ; 2011 Mar; 342():d1304. PubMed ID: 21363849 [No Abstract] [Full Text] [Related]